LIP
BBIO icon

Lighthouse Investment Partners’s BridgeBio Pharma BBIO Stock Holding History

Lighthouse Investment Partners’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-70,000
Closed -$1.92M – 480
2024
Q4 		$1.92M Buy
+70,000
New +$1.81M 0.06% 291

Other funds holding BBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lighthouse Investment Partners's BBIO Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of BridgeBio Pharma (BBIO) in Q1 2026, closing a stake of 13,000 shares — an estimated $994K sold.

Lighthouse Investment Partners first reported a position in BBIO in Q1 2024 and held it in 5 quarters. The position peaked at $3.43M in Q4 2024. 458 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining BridgeBio Pharma position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 13,000 BridgeBio Pharma shares in Q1 2026, an estimated $994K.
  • Lighthouse Investment Partners first reported a position in BridgeBio Pharma in Q1 2024 and held it in 5 quarters.
  • Lighthouse Investment Partners's BridgeBio Pharma position peaked at $3.43M in Q4 2024.
  • 458 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.